Clinical Trial Update: 68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis [EARLY_Phase 1]

View source ↗

Summary

This document covers an early-phase 1 clinical trial evaluating 68Ga-NOTA-PRGD2 PET/CT imaging in patients with lung injury and pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• 68Ga-NOTA-PRGD2 (NOTA-PRGD2)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pulmonary Fibrosis, Unspecified | EARLY_Phase 1 | Status: UNKNOWN